METHODS OF TREATING GRAFT VERSUS HOST DISEASE USING IL-2 MUTEINS
- 专利权人:
- Amgen Inc.
- 发明人:
- Marc A. GAVIN,Li LI
- 申请号：
- US15649520
- 公开号：
- US20170313753A1
- 申请日:
- 2017.07.13
- 申请国别(地区):
- US
- 年份:
- 2017
- 代理人:
- 摘要：
- Described herein are immunosuppressive molecules including immunosuppressive variants of IL-2, and use of such molecules to treat inflammatory and autoimmune disorders.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Method of treating graft versus host disease using IL-2 muteins
- TREATMENT OF AUTOIMMUNE DISEASE
- METHODS FOR TREATING OR PREVENTING GRAFT VERSUS HOST DISEASE
- USE OF TELMISARTAN TO PREVENT AND TREAT GRAFT VERSUS HOST DISEASE AND OTHER ALLOIMMUNE AND AUTOIMMUNE DISEASES
- TREATMENT OF INFLAMMATORY DISORDERS
